6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01547741 [Disease Site] Breast Cancer [Description] 
A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description